Nectar Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Dec' 24	Sep' 24	Jun' 24	Mar' 24	Dec' 23

Sales

454.98

428.10

359.30

441.37

452.17

Operating profit

44.71

43.33

39.80

48.51

42.19

Interest

17.12

19.81

19.98

24.16

24.84

Gross profit

28.16

24.21

20.38

25.82

17.83

EPS (Rs)

0.35

0.25

0.13

0.03

0.07

Other income

0.57

0.69

0.55

1.47

0.48

Stock adjustment

37.89

42.16

-59.64

-52.39

-14.96

Raw material

294.15

253.89

296.98

360.32

342.32

Power and fuel

-

-

-

-

-

Employee expenses

24.50

24.18

23.99

23.94

21.62

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

53.73

64.54

58.17

61.00

60.99

Provisions made

-

-

-

-

-

Depreciation

15.61

15.55

15.46

14.70

15.37

Taxation

4.71

3.07

1.95

10.52

0.89

Net profit / loss

7.84

5.60

2.97

0.60

1.57

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

22.43

22.43

22.43

22.43

22.43

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

9.83

10.12

11.08

10.99

9.33

GPM (%)

6.18

5.65

5.66

5.83

3.94

NPM (%)

1.72

1.31

0.83

0.14

0.35